{
    "Trade/Device Name(s)": [
        "Element\u2122 Blood Glucose Monitoring System",
        "Element\u2122 Test Strips",
        "Element\u2122 Control Solutions"
    ],
    "Submitter Information": "Infopia Co.,Ltd.",
    "510(k) Number": "K113670",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103021"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "April 6, 2012",
    "Summary Letter Received Date": "April 12, 2012",
    "Submission Date": "April 27, 2012",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Element\u2122 Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [
        "In vitro quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Test Strips",
        "Control Solutions",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for Element\u2122 Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood using electrochemical detection",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in capillary whole blood from multiple body sites for single-patient home use as an aid in diabetes management; not for diagnosis or screening of diabetes or neonatal use",
    "fda_folder": "Clinical Chemistry"
}